Expression of B-cell-specific markers in different Burkitt lymphoma subgroups

Area of Science:

• * Hematology
• * Immunology
• * Oncology

Background:

• * Burkitt lymphoma (BL) is a B-cell malignancy with distinct EBV association.
• * B-cell maturation involves specific surface marker expression and immunoglobulin production.
• * Translocations, particularly t(8;14), are characteristic of BL and may influence B-cell differentiation.

Purpose of the Study:

• * To investigate the expression of B-cell-specific markers in EBV-negative and EBV-carrying BL cell lines.
• * To determine the impact of EBV infection on B-cell maturation pathways in BL.
• * To re-evaluate the association between translocation types and marker expression in BL.

Main Methods:

• * Analysis of 5 monoclonal antibody (MAb)-identified B-cell-specific markers and immunoglobulin production in 43 BL cell lines.
• * Comparison of marker expression patterns between EBV-negative and EBV-carrying BL lines.
• * Examination of marker changes in EBV-converted BL sublines and correlation with translocation types.

Main Results:

• * EBV-negative BL lines consistently expressed CALLA+ LB-1-, with concordant BA-1 and 35.1C5 expression and an inverted correlation between 35.1C5 and BLA.
• * EBV-carrying BL lines exhibited heterogeneous marker patterns, with disrupted coordination of BA-1/35.1C5 and the 35.1C5/BLA relationship.
• * EBV conversion led to marker changes, and EBV-carrying variant translocations showed a significant association with CALLA- LB-1+ phenotype compared to typical translocations.

Conclusions:

• * EBV significantly interferes with the B-cell maturation program in Burkitt lymphoma.
• * The presence of EBV alters the expression of key B-cell surface markers, leading to aberrant differentiation.
• * EBV's influence on marker expression may be linked to specific translocation subtypes in BL.